Recce Pharmaceuticals Ltd. announced the appointment of Alan W. Dunton, M.D., to its Board of Directors as an independent Non- Executive Director and as a member of the Company's Audit & Risk and Remuneration & Nomination Committees. Alan currently serves on the boards of Oragenics Inc., Palatin Technologies Inc., Cormedix Inc. and Regeneus Ltd.